DK1320542T3 - Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf - Google Patents

Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf

Info

Publication number
DK1320542T3
DK1320542T3 DK01959633T DK01959633T DK1320542T3 DK 1320542 T3 DK1320542 T3 DK 1320542T3 DK 01959633 T DK01959633 T DK 01959633T DK 01959633 T DK01959633 T DK 01959633T DK 1320542 T3 DK1320542 T3 DK 1320542T3
Authority
DK
Denmark
Prior art keywords
polypeptides
nucleic acids
ema
streptococcal
group
Prior art date
Application number
DK01959633T
Other languages
English (en)
Inventor
Elisabeth Adderson
John Bohnsack
Original Assignee
St Jude Childrens Res Hospital
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Res Hospital, Univ Utah Res Found filed Critical St Jude Childrens Res Hospital
Application granted granted Critical
Publication of DK1320542T3 publication Critical patent/DK1320542T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01959633T 2000-08-08 2001-08-08 Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf DK1320542T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63434100A 2000-08-08 2000-08-08
PCT/US2001/024795 WO2002012294A2 (en) 2000-08-08 2001-08-08 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof

Publications (1)

Publication Number Publication Date
DK1320542T3 true DK1320542T3 (da) 2007-09-10

Family

ID=24543390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01959633T DK1320542T3 (da) 2000-08-08 2001-08-08 Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf

Country Status (11)

Country Link
US (2) US7128919B2 (da)
EP (2) EP1320542B9 (da)
AT (1) ATE360640T1 (da)
AU (1) AU2001281168A1 (da)
CA (1) CA2417357A1 (da)
CY (1) CY1107702T1 (da)
DE (1) DE60128115T2 (da)
DK (1) DK1320542T3 (da)
ES (1) ES2286133T3 (da)
PT (1) PT1320542E (da)
WO (1) WO2002012294A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP1597348A4 (en) * 2002-08-26 2010-03-31 Novartis Vaccines & Diagnostic GENES OF STREPTOCOCCUS PRESERVED OR SPECIFIC
CA2532369C (en) * 2003-07-31 2016-07-26 Chiron Corporation Immunogenic compositions for streptococcus pyogenes
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
CA2575548A1 (en) * 2004-07-29 2006-07-27 John L. Telford Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1786908B1 (en) * 2004-08-18 2010-03-03 Bayer CropScience AG Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
CA2583803C (en) * 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
US7858101B2 (en) 2004-11-01 2010-12-28 The Brigham And Women's Hospital, Inc. Modified streptococcal polysaccharides and uses thereof
GB0502095D0 (en) 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
WO2008020335A2 (en) * 2006-06-09 2008-02-21 Novartis Ag Immunogenic compositions for streptococcus agalactiae
EP2094297A2 (en) * 2006-10-30 2009-09-02 Novartis AG Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2009034473A2 (en) 2007-09-12 2009-03-19 Novartis Ag Gas57 mutant antigens and gas57 antibodies
CN101977926B (zh) 2007-12-21 2014-10-08 诺华股份有限公司 链球菌溶血素o的突变形式
AU2010203698B2 (en) 2009-01-06 2016-07-21 C3 Jian, Inc. Targeted antimicrobial moieties
MX2011007456A (es) * 2009-01-12 2011-08-03 Novartis Ag Antigenos del dominio de proteina de superficie de union a colageno tipo b (can_b) en vacunas contra bacteria gram positiva.
WO2012078482A1 (en) * 2010-12-10 2012-06-14 Merck Sharp & Dohme Corp. Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
BR112021022429A2 (pt) 2019-05-10 2022-03-22 Glaxosmithkline Biologicals Sa Produção de conjugados
CN115287244B (zh) * 2022-06-28 2023-07-25 北部湾大学 鱼源无乳链球菌internalin基因LRR结构域敲除突变株及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4356263A (en) 1980-06-09 1982-10-26 President And Fellows Of Harvard College Method of making a polysaccharide vaccine
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
CA2006596C (en) 1988-12-22 2000-09-05 Rika Ishikawa Chemically-modified g-csf
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5139749A (en) 1990-06-22 1992-08-18 Tas, Inc. Fluidized calcining process
JPH06505486A (ja) 1991-02-07 1994-06-23 モレキュメティクス，リミティド βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
NZ299249A (en) 1992-09-24 2000-08-25 Brigham & Womens Hospital Use of an antigenic conjugate of a capsular polysaccharide from streptococcus and a protein component to immunise neonates
ZA937034B (en) 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
DK1310510T3 (da) 1993-05-27 2007-09-24 Aventis Pharma Inc Topologisk adsilte, kodede biblioteker med fast fase
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
EP0942982A1 (en) 1996-02-29 1999-09-22 Washington University Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
US6448043B1 (en) 1997-05-06 2002-09-10 Human Genome Sciences, Inc. Enterococcus faecalis EF040 and uses therefor
JP2002531055A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌のタンパク質及び核酸分子
JP2002531054A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Ｂ群連鎖球菌由来の核酸およびタンパク質
WO2000012132A1 (en) 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
CA2365523A1 (en) 1999-04-15 2000-10-26 The Regents Of The University Of California Identification of sortase gene
AU5755500A (en) 1999-06-21 2001-01-09 University Of Utah Research Foundation Isolated genes from virulent group B streptococcus agalactiae
US9002545B2 (en) 2011-01-07 2015-04-07 Wabtec Holding Corp. Data improvement system and method

Also Published As

Publication number Publication date
EP1810978A3 (en) 2007-10-24
AU2001281168A1 (en) 2002-02-18
DE60128115T2 (de) 2008-03-06
EP1810978B1 (en) 2013-02-13
US7128919B2 (en) 2006-10-31
EP1810978A2 (en) 2007-07-25
EP1320542B9 (en) 2007-09-12
PT1320542E (pt) 2007-08-06
US7645577B2 (en) 2010-01-12
ES2286133T3 (es) 2007-12-01
WO2002012294A2 (en) 2002-02-14
CA2417357A1 (en) 2002-02-14
DE60128115D1 (de) 2007-06-06
EP1320542A2 (en) 2003-06-25
WO2002012294A3 (en) 2003-04-10
US20040071729A1 (en) 2004-04-15
CY1107702T1 (el) 2013-04-18
EP1320542B1 (en) 2007-04-25
ATE360640T1 (de) 2007-05-15
US20070178116A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
DK1320542T3 (da) Gruppe B streptokokpolypeptider-nukleinsyrer og terapeutiske sammensætninger og vacciner deraf
IL264925A (en) Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses
EP3167900B1 (en) Vaccine against streptococci
WO2002083855A3 (en) Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
AR003124A1 (es) Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,
NZ551802A (en) A hyperimmune serum-reactive antigen consisting of a polypeptide comprising an amino acid sequence in SEQ ID NO:422 and antigenic fragments thereof
HUP0500459A2 (hu) Streptococcus suis vakcinák és diagnosztikai tesztek
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
EA007409B1 (ru) Антигенные полипептиды стрептококков, способы их получения и применения
KR20070101197A (ko) 유전자와 단백질들, 및 그들의 사용
JP2009542196A (ja) 小型の化膿連鎖球菌抗原およびそれらの使用
WO2002050277A3 (en) Protein and nucleic acids encoding same
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
Cullen et al. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli
WO2004020609A3 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
CA2718473A1 (en) Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
Chessa et al. Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
EP2450053B1 (en) Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
KR20080052693A (ko) 유전자, 단백질 및 그들의 용도
WO2002050276A3 (en) Proteins and nucleic acids encoding same
HUP0200832A2 (hu) Babesia canis oltóanyag
NZ512448A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ311874A (en) Recombinant and/or pure preparations of H. pylori polypeptides and nucleic acids which are useful for diagnostics and vaccines